Weekly IPOs | Helens made a brilliant debut, and two major medical IPOs are about to hit
Novell Health, the largest biotech CRO company in the Asia-Pacific region, passed the hearing; Helens, the “first tavern stock”, closed up 22.91% on the first day, with a market capitalization exceeding HK$30 billion.
Kumbo Medical passed the Hong Kong Stock Exchange listing hearing and ranked first in the Chinese interventional respiratory navigation equipment market in terms of sales
According to the official website of the Hong Kong Stock Exchange, Broncus Healthcare (Broncus) has successfully passed the Hong Kong Stock Exchange listing hearing, and Goldman Sachs and Haitong International are its co-sponsors. Established in 2012, Kumbo Medical is a pioneer in the field of interventional respiratory medicine, providing innovative lung disease solutions in China and around the world. The interventional respiratory navigation equipment market in China mainly includes four major companies, including Broncus. As of 2018, 2019 and the year ending 2020, Broncus ranked first in terms of sales in the Chinese interventional respiratory navigation equipment market, with a market share of 43.2%
According to HKEx documents: medical device company Bo Medical Holdings Co., Ltd. is listed on the Hong Kong Stock Exchange to hear the hearing.
According to HKEx documents: medical device company Bo Medical Holdings Co., Ltd. is listed on the Hong Kong Stock Exchange to hear the hearing.
No Data